Biotoxtech Co., Ltd. (KOSDAQ:086040)
2,445.00
+50.00 (2.09%)
At close: Jun 18, 2026
Biotoxtech Revenue
Biotoxtech had revenue of 11.87B KRW in the quarter ending March 31, 2026, with 5.51% growth. This brings the company's revenue in the last twelve months to 47.64B, up 9.26% year-over-year. In the year 2025, Biotoxtech had annual revenue of 47.02B with 13.73% growth.
Revenue (ttm)
47.64B
Revenue Growth
+9.26%
P/S Ratio
0.81
Revenue / Employee
253.38M
Employees
188
Market Cap
38.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.02B | 5.68B | 13.73% |
| Dec 31, 2024 | 41.34B | 8.71B | 26.69% |
| Dec 31, 2023 | 32.63B | -4.66B | -12.50% |
| Dec 31, 2022 | 37.29B | 4.57B | 13.98% |
| Dec 31, 2021 | 32.72B | 6.29B | 23.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| S Connect Co., LTD. | 253.43B |
| Green Plus | 115.20B |
| Carelabs Co.,Ltd | 79.17B |
| TKG Aikang | 70.50B |
| Milae Bioresources | 69.89B |
| KD Chem | 64.11B |
| Korean Drug | 62.76B |
| Dexter Studios | 51.01B |